Form 4 Tracker
Arcutis Biotherapeutics, Inc.
ARQT

32 insider filings · Latest: Jun 15, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jun 15, 2026Jun 18 12:47 AMSue-Jean LinDirector
Sale
4,946$24.38$120.6K27,567(D)

View →

Jun 17, 2026Jun 18 12:40 AMHoward G. WelgusDirector
Sale
635$25.67$16.3K37,743(D)

View →

Jun 15, 2026Jun 18 12:40 AMHoward G. WelgusDirector
Sale
4,096$24.41$100.0K38,378(D)

View →

Jun 17, 2026Jun 17 8:08 PMHoward Welgus
Proposed Sale
635$25.67$16.3K

View →

Jun 15, 2026Jun 15 8:11 PMSue-Jean Lin
Proposed Sale
4,946$24.38$120.6K

View →

Jun 15, 2026Jun 15 8:11 PMHoward Welgus
Proposed Sale
4,096$24.41$100.0K

View →

May 11, 2026May 13 11:43 PMLatha VairavanSVP Chief Financial Officer
Sale
435$21.05$9.2K85,978(D)

View →

May 11, 2026May 13 11:42 PMPatrick BurnettReporting Person's Title: EVP, Chief Medical Officer
Sale
222$21.05$4.7K120,244(D)

View →

May 11, 2026May 11 8:44 PMPatrick Burnett
Proposed Sale
222$21.05$4.7K

View →

May 11, 2026May 11 8:35 PMLatha Vairavan
Proposed Sale
435$21.05$9.2K

View →

May 4, 2026May 6 11:40 PMMasaru MatsudaReporting Person's title: EVP, Chief Legal Officer
Sale
8,256$23.31$192.4K126,689(D)

View →

May 4, 2026May 6 10:15 PMPatrick BurnettReporting Person's Title: EVP, Chief Medical Officer
Sale
684$23.61$16.1K120,466(D)

View →

May 4, 2026May 6 10:13 PMLatha VairavanSVP Chief Financial Officer
Sale
1,341$23.61$31.7K86,413(D)

View →

May 4, 2026May 6 10:06 PMTodd WatanabeDirector, Reporting Person's title: President and Chief Executive Officer
Sale
3,172$23.61$74.9K720,755(D)

View →

May 1, 2026May 6 12:21 AMHoward G. WelgusDirector
Sale
7,144$22.99$164.2K32,600(D)

View →

May 4, 2026May 4 9:19 PMPatrick Burnett
Proposed Sale
684$23.61$16.1K

View →

May 4, 2026May 4 9:18 PMLatha Vairavan
Proposed Sale
1,341$23.61$31.7K

View →

May 4, 2026May 4 9:18 PMTodd Watanabe
Proposed Sale
3,172$23.61$74.9K

View →

May 4, 2026May 4 9:05 PMMasaru Matsuda
Proposed Sale
8,256$23.31$192.4K

View →

May 1, 2026May 1 8:04 PMHoward Welgus
Proposed Sale
7,144$22.99$164.2K

View →

Page 1 of 7

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 15, 2026Jun 18 12:40 AMHoward G. WelgusDirector
Option Exercise
4,096$8.6324,797(D)

View →

Jun 5, 2026Jun 10 1:21 AMPatrick J HeronDirector
Grant/Award
16,667$21.2316,667(D)

View →

Jun 5, 2026Jun 10 1:21 AMSue-Jean LinDirector
Grant/Award
16,667$21.2316,667(D)

View →

Jun 5, 2026Jun 10 1:21 AMHoward G. WelgusDirector
Grant/Award
16,667$21.2316,667(D)

View →

Jun 5, 2026Jun 10 1:21 AMKeith R LeonardDirector
Grant/Award
16,667$21.2316,667(D)

View →

Jun 5, 2026Jun 10 1:21 AMTerrie CurranDirector
Grant/Award
16,667$21.2316,667(D)

View →

Jun 5, 2026Jun 10 1:21 AMAmit MunshiDirector
Grant/Award
16,667$21.2316,667(D)

View →

Jun 5, 2026Jun 10 1:20 AMHalley E GilbertDirector
Grant/Award
16,667$21.2316,667(D)

View →

Jun 5, 2026Jun 10 1:20 AMNeha KrishnamohanDirector
Grant/Award
16,667$21.2316,667(D)

View →

Mar 2, 2026Mar 4 9:17 PMKeith R LeonardDirector
Option Exercise
39,272$8.630(D)

View →

Feb 27, 2026Mar 4 1:43 AMLarry Todd EdwardsReporting Person's title: EVP, Chief Commercial Officer
Grant/Award
77,000$26.9777,000(D)

View →

Feb 27, 2026Mar 4 1:42 AMTodd WatanabeDirector, Reporting Person's title: President and Chief Executive Officer
Grant/Award
266,000$26.97266,000(D)

View →

Feb 27, 2026Mar 4 1:42 AMMasaru MatsudaReporting Person's title: EVP, Chief Legal Officer
Grant/Award
97,000$26.9797,000(D)

View →

Feb 27, 2026Mar 4 1:42 AMLatha VairavanSVP Chief Financial Officer
Grant/Award
70,000$26.9770,000(D)

View →

Feb 27, 2026Mar 4 1:41 AMPatrick BurnettReporting Person's title: EVP, Chief Medical Officer
Grant/Award
77,000$26.9777,000(D)

View →